Next Article in Journal
Molecular Characterization of Antimicrobial Resistance in Clinical Shigella Isolates During 2014 and 2015: Trends in South India
Previous Article in Journal
Simplified Protocol of Gel-Based Multiple Locus Variable Number of Tandem Repeats Analysis (MLVA) for Staphylococcus aureus Typing
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

2-Drug Regimens in HIV Treatment: Pharmacological Considerations

Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool L693GF, UK
GERMS 2017, 7(3), 113-114; https://doi.org/10.18683/germs.2017.1115
Submission received: 1 June 2017 / Revised: 1 July 2017 / Accepted: 1 August 2017 / Published: 1 September 2017

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Three-drug combination antiretroviral therapy (ART) based on two nucleos(t)ide reverse transcriptase inhibitors (N(t)RTIs) plus a third agent from another antiretroviral class has been the treatment paradigm that has resulted in life expectancy of HIV-infected subjects approaching that of the general population [...]

Share and Cite

MDPI and ACS Style

Back, D. 2-Drug Regimens in HIV Treatment: Pharmacological Considerations. GERMS 2017, 7, 113-114. https://doi.org/10.18683/germs.2017.1115

AMA Style

Back D. 2-Drug Regimens in HIV Treatment: Pharmacological Considerations. GERMS. 2017; 7(3):113-114. https://doi.org/10.18683/germs.2017.1115

Chicago/Turabian Style

Back, David. 2017. "2-Drug Regimens in HIV Treatment: Pharmacological Considerations" GERMS 7, no. 3: 113-114. https://doi.org/10.18683/germs.2017.1115

APA Style

Back, D. (2017). 2-Drug Regimens in HIV Treatment: Pharmacological Considerations. GERMS, 7(3), 113-114. https://doi.org/10.18683/germs.2017.1115

Article Metrics

Back to TopTop